Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
news_6

Last Chance to Experience Asahi Kasei’s AKXY Pod Future Automotive Interior Prototype and Crystal IS to Present Klaran® UVC LED Whitepaper at SAE WCX 2022

Visit us at booth 434 at SAE WCX in Detroit from April 5-7, 2022 NEW YORK & NOVI, Mich.--(BUSINESS WIRE)--#asahikasei--Asahi...

news_6

Bio-Thera Solutions Announces First Patient Dosed in a Phase 1 Study in Australia Evaluating BAT6026, an Anti-OX40 Antibody with Enhanced ADCC Effect, in Combination with BAT1308, an Anti-PD-1 Antibody

GUANGZHOU, China--(BUSINESS WIRE)--#AdvancedSolidTumor--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase 1...

news_6

India’s Professional Online Courses Market is Expected to Grow at a CAGR of over 15.78% During 2022-2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Professional Online Courses Market in India 2022-2026" report has been added to ResearchAndMarkets.com's offering. India's professional online courses...

news_6

Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

news_6

Fujirebio Confirms Its Engagement in Blood-based Alzheimer’s Disease Biomarker Testing with the Launch of the Fully Automated Lumipulse® G ?-Amyloid 1-42 and ?-Amyloid 1-40 Plasma Assays for Research Use Only

GENT, Belgium & MALVERN, Pa. & TOKYO--(BUSINESS WIRE)--#FNCoE--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability...